Dr Michael John Koriwchak, MD | |
5673 Peachtree Dunwoody Rd, Ste 150, Atlanta, GA 30342-1731 | |
(404) 297-1780 | |
(404) 252-7255 |
Full Name | Dr Michael John Koriwchak |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 36 Years |
Location | 5673 Peachtree Dunwoody Rd, Atlanta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720085756 | NPI | - | NPPES |
00663935AF | Medicaid | GA | |
5576015 | Other | GA | AETNA |
52448442 | Other | GA | BCBS OF GEORGIA |
8306705 | Other | GA | CIGNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 040130 (Georgia) | Primary |
207YS0012X | Otolaryngology - Sleep Medicine | 040130 (Georgia) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Northside Hospital | Atlanta, GA | Hospital |
Northside Hospital Forsyth | Cumming, GA | Hospital |
Emory Decatur Hospital | Decatur, GA | Hospital |
Saint Joseph's Hospital Of Atlanta, Inc | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Georgia Surgical Professional Services Llc | 3375774011 | 47 |
News Archive
The new 2010 Cumulative Supplement to Managed Care Litigation is a practical reference written specifically for practitioners who handle managed care disputes to help them rapidly focus on key issues and expertly advise their clients. The supplement and its main volume are published by BNA Books, a division of specialized news and information publisher BNA, in conjunction with the American Bar Association Health Law Section.
Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women - as many as 50% of women will experience at least one UTI during their lifetime.
UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.
Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
› Verified 9 days ago
Entity Name | Ent Of Georgia, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922046424 PECOS PAC ID: 1557254109 Enrollment ID: O20040206000068 |
News Archive
The new 2010 Cumulative Supplement to Managed Care Litigation is a practical reference written specifically for practitioners who handle managed care disputes to help them rapidly focus on key issues and expertly advise their clients. The supplement and its main volume are published by BNA Books, a division of specialized news and information publisher BNA, in conjunction with the American Bar Association Health Law Section.
Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women - as many as 50% of women will experience at least one UTI during their lifetime.
UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.
Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
› Verified 9 days ago
Entity Name | Georgia Surgical Professional Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801224506 PECOS PAC ID: 3375774011 Enrollment ID: O20140324000595 |
News Archive
The new 2010 Cumulative Supplement to Managed Care Litigation is a practical reference written specifically for practitioners who handle managed care disputes to help them rapidly focus on key issues and expertly advise their clients. The supplement and its main volume are published by BNA Books, a division of specialized news and information publisher BNA, in conjunction with the American Bar Association Health Law Section.
Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women - as many as 50% of women will experience at least one UTI during their lifetime.
UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.
Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael John Koriwchak, MD 5673 Peachtree Dunwoody Rd, Ste 150, Atlanta, GA 30342-1731 Ph: (404) 297-1780 | Dr Michael John Koriwchak, MD 5673 Peachtree Dunwoody Rd, Ste 150, Atlanta, GA 30342-1731 Ph: (404) 297-1780 |
News Archive
The new 2010 Cumulative Supplement to Managed Care Litigation is a practical reference written specifically for practitioners who handle managed care disputes to help them rapidly focus on key issues and expertly advise their clients. The supplement and its main volume are published by BNA Books, a division of specialized news and information publisher BNA, in conjunction with the American Bar Association Health Law Section.
Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women - as many as 50% of women will experience at least one UTI during their lifetime.
UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.
Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
› Verified 9 days ago
David Wei-hau Chou, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3200 Downwood Cir Nw Ste 640, Atlanta, GA 30327 Phone: 404-778-6880 | |
Dr. Peter Jay Abramson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5673 Peachtree Dunwoody Rd, Ste 150, Atlanta, GA 30342 Phone: 404-297-1780 Fax: 404-252-7255 | |
Dr. Michael Douglas Hellstrom, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 20 Glenlake Pkwy, Kaiser Permanente Medical Group Glenlake, Atlanta, GA 30328 Phone: 404-365-0966 Fax: 864-716-7738 | |
Donald Patrick Dennis, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 3193 Howell Mill Rd, #215, Atlanta, GA 30327 Phone: 404-355-1312 Fax: 404-352-2798 | |
Dr. Clementino Arturo Solares, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 550 Peachtree St Ne Ste 1135, Atlanta, GA 30308 Phone: 404-778-3381 Fax: 216-445-9409 | |
Wiley A Parker, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5669 Peachtree Dunwoody Rd N, Ste 295, Atlanta, GA 30342 Phone: 404-256-9822 Fax: 404-256-0250 | |
Sarah K Wise, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Emory Department Of Otolaryngology, 1365a Clifton Road Ne, Suite A2300, Atlanta, GA 30322 Phone: 404-778-3381 |